Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.

The race to greenlight a COVID-19 vaccine in the United States has entered its final sprint, with one leading candidate becoming the first to release preliminary results showing its vaccine is more ...

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

Pfizer PFE has committed significant resources toward the development of treatments in the fields of oncology, metabolic ...